ReviewMolecular medicine (Cambridge, Mass.)1999
Inhibition of complement as a therapeutic approach in inflammatory central nervous system (CNS) disease.
Review in Molecular medicine (Cambridge, Mass.), 1999. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed, 45 citations in OpenAlex.
- Appropriate exercise level attenuates gut dysbiosis and valeric acid increase to improve neuroplasticity and cognitive function after surgery in mice.Molecular psychiatry · 2021Article
- Protective Effects of Curcumin Against Ischemia-Reperfusion Injury in the Nervous System.Molecular neurobiology · 2019Review
- The neuropathological basis to the functional role of microglia/macrophages in gliomas.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2017Review
- Ischemia-reperfusion Injury in the Brain: Mechanisms and Potential Therapeutic Strategies.Biochemistry & pharmacology : open access · 2016Article
- The molecular profile of microglia under the influence of glioma.Neuro-oncology · 2012Review
- Molecular mechanisms of inflammation and tissue injury after major trauma--is complement the "bad guy"?Journal of biomedical science · 2011Review
- The role of microglia in central nervous system immunity and glioma immunology.Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia · 2010Review
- Mechanisms and implications of adaptive immune responses after traumatic spinal cord injury.Neuroscience · 2009Review
- Absence of the complement regulatory molecule CD59a leads to exacerbated neuropathology after traumatic brain injury in mice.Journal of neuroinflammation · 2009Article
- Post-translational modifications in the rat lumbar spinal cord in experimental autoimmune encephalomyelitis.Journal of proteome research · 2007Article
- Inhibition of the alternative complement activation pathway in traumatic brain injury by a monoclonal anti-factor B antibody: a randomized placebo-controlled study in mice.Journal of neuroinflammation · 2007Article
- [The relevance of the inflammatory response in the injured brain].Der Orthopade · 2007Review
- Reduced neuronal cell death after experimental brain injury in mice lacking a functional alternative pathway of complement activation.BMC neuroscience · 2006Article
- Complement in central nervous system inflammation.Immunologic research · 2002Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author at 1 institution in 1 country.
Funding
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
10551898PMC2230464W1989877055What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.